Preliminary Findings of High-Dose Thiamine in Dementia of Alzheimer's Type

K. Meador, D. Loring, M. Nichols, E. Zamrini, M. Rivner, H. Posas, E. Thompson, E. Moore

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Thiamine is important not only in the metabolism of acetylcholine but also in its release from the presynaptic neuron. Pathologic, clinical, and biochemical data suggest that thiamine deficiency is detrimental to the cholinergic system and that thiamine-dependent enzymes may be altered in Alzheimer's disease. Two previous studies reported contradictory results in patients with dementia of Alzheimer's type treated with 3 g/day of thiamine. In the present study, we examined the effects of 3 to 8 g/day thiamine administered orally. Our results suggest that thiamine at these pharmacologic dosages may have a mild beneficial effect in dementia of Alzheimer's type. The mechanism of the observed effect is unknown, but the findings warrant further investigation, not only for their therapeutic implications but for their possible etiologic clues. In addition, the results suggest long-term carry-over effects that should be considered in the design of future studies.

Original languageEnglish (US)
Pages (from-to)222-229
Number of pages8
JournalJournal of Geriatric Psychiatry and Neurology
Volume6
Issue number4
DOIs
StatePublished - Jan 1 1993

Fingerprint

Thiamine
Alzheimer Disease
Thiamine Deficiency
Cholinergic Agents
Acetylcholine
Neurons
Enzymes

ASJC Scopus subject areas

  • Clinical Neurology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Preliminary Findings of High-Dose Thiamine in Dementia of Alzheimer's Type. / Meador, K.; Loring, D.; Nichols, M.; Zamrini, E.; Rivner, M.; Posas, H.; Thompson, E.; Moore, E.

In: Journal of Geriatric Psychiatry and Neurology, Vol. 6, No. 4, 01.01.1993, p. 222-229.

Research output: Contribution to journalArticle

Meador, K, Loring, D, Nichols, M, Zamrini, E, Rivner, M, Posas, H, Thompson, E & Moore, E 1993, 'Preliminary Findings of High-Dose Thiamine in Dementia of Alzheimer's Type', Journal of Geriatric Psychiatry and Neurology, vol. 6, no. 4, pp. 222-229. https://doi.org/10.1177/089198879300600408
Meador, K. ; Loring, D. ; Nichols, M. ; Zamrini, E. ; Rivner, M. ; Posas, H. ; Thompson, E. ; Moore, E. / Preliminary Findings of High-Dose Thiamine in Dementia of Alzheimer's Type. In: Journal of Geriatric Psychiatry and Neurology. 1993 ; Vol. 6, No. 4. pp. 222-229.
@article{20325bd87cbe4b12888b6137ae1cd475,
title = "Preliminary Findings of High-Dose Thiamine in Dementia of Alzheimer's Type",
abstract = "Thiamine is important not only in the metabolism of acetylcholine but also in its release from the presynaptic neuron. Pathologic, clinical, and biochemical data suggest that thiamine deficiency is detrimental to the cholinergic system and that thiamine-dependent enzymes may be altered in Alzheimer's disease. Two previous studies reported contradictory results in patients with dementia of Alzheimer's type treated with 3 g/day of thiamine. In the present study, we examined the effects of 3 to 8 g/day thiamine administered orally. Our results suggest that thiamine at these pharmacologic dosages may have a mild beneficial effect in dementia of Alzheimer's type. The mechanism of the observed effect is unknown, but the findings warrant further investigation, not only for their therapeutic implications but for their possible etiologic clues. In addition, the results suggest long-term carry-over effects that should be considered in the design of future studies.",
author = "K. Meador and D. Loring and M. Nichols and E. Zamrini and M. Rivner and H. Posas and E. Thompson and E. Moore",
year = "1993",
month = "1",
day = "1",
doi = "10.1177/089198879300600408",
language = "English (US)",
volume = "6",
pages = "222--229",
journal = "Journal of Geriatric Psychiatry and Neurology",
issn = "0891-9887",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Preliminary Findings of High-Dose Thiamine in Dementia of Alzheimer's Type

AU - Meador, K.

AU - Loring, D.

AU - Nichols, M.

AU - Zamrini, E.

AU - Rivner, M.

AU - Posas, H.

AU - Thompson, E.

AU - Moore, E.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Thiamine is important not only in the metabolism of acetylcholine but also in its release from the presynaptic neuron. Pathologic, clinical, and biochemical data suggest that thiamine deficiency is detrimental to the cholinergic system and that thiamine-dependent enzymes may be altered in Alzheimer's disease. Two previous studies reported contradictory results in patients with dementia of Alzheimer's type treated with 3 g/day of thiamine. In the present study, we examined the effects of 3 to 8 g/day thiamine administered orally. Our results suggest that thiamine at these pharmacologic dosages may have a mild beneficial effect in dementia of Alzheimer's type. The mechanism of the observed effect is unknown, but the findings warrant further investigation, not only for their therapeutic implications but for their possible etiologic clues. In addition, the results suggest long-term carry-over effects that should be considered in the design of future studies.

AB - Thiamine is important not only in the metabolism of acetylcholine but also in its release from the presynaptic neuron. Pathologic, clinical, and biochemical data suggest that thiamine deficiency is detrimental to the cholinergic system and that thiamine-dependent enzymes may be altered in Alzheimer's disease. Two previous studies reported contradictory results in patients with dementia of Alzheimer's type treated with 3 g/day of thiamine. In the present study, we examined the effects of 3 to 8 g/day thiamine administered orally. Our results suggest that thiamine at these pharmacologic dosages may have a mild beneficial effect in dementia of Alzheimer's type. The mechanism of the observed effect is unknown, but the findings warrant further investigation, not only for their therapeutic implications but for their possible etiologic clues. In addition, the results suggest long-term carry-over effects that should be considered in the design of future studies.

UR - http://www.scopus.com/inward/record.url?scp=0027494848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027494848&partnerID=8YFLogxK

U2 - 10.1177/089198879300600408

DO - 10.1177/089198879300600408

M3 - Article

VL - 6

SP - 222

EP - 229

JO - Journal of Geriatric Psychiatry and Neurology

JF - Journal of Geriatric Psychiatry and Neurology

SN - 0891-9887

IS - 4

ER -